Pfizer to acquire Rouses Point Plant from Akrimax - MarketLine Financial Deals

Pfizer to acquire Rouses Point Plant from Akrimax

Pfizer to acquire Rouses Point Plant from Akrimax - MarketLine Financial Deals
Pfizer to acquire Rouses Point Plant from Akrimax
Published Jun 29, 2011
2 pages — Published Jun 29, 2011
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Pfizer, Inc., a research-based biopharmaceutical company, has exercised its option to acquire Rouses Point Plant from Akrimax Pharmaceutical, LLC.

  
Source:
Document ID
MA69196_110701
Country
Ticker
PFE=US
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Pfizer to acquire Rouses Point Plant from Akrimax" Jun 29, 2011. Alacra Store. Dec 09, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Pfizer-to-acquire-Rouses-Point-Plant-from-Akrimax-2052-63527>
  
APA:
MarketLine Financial Deals. (2011). Pfizer to acquire Rouses Point Plant from Akrimax Jun 29, 2011. New York, NY: Alacra Store. Retrieved Dec 09, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Pfizer-to-acquire-Rouses-Point-Plant-from-Akrimax-2052-63527>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.